Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer¿s Disease Grant

Assessment of Safety and Efficacy of Exablate Blood-Brain Barrier Disruption for the Treatment of Patients with Probable Alzheimer¿s Disease .

date/time interval

  • November 2, 2021 - November 1, 2028

awarded by

administered by

sponsor award ID

  • NCT03671889

contributor